NVO
Novo Nordisk A S
$49.28
-0.20 (-0.40%)
At close · Jul 13
Market Cap
$218.05B
Shares
3,349,933,520
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
51/100
Short interest 0.8% of shares — P38
Days to cover 2.2 — P48
Price vs VWAP +12.3% — P89
Short-volume trend -3.6% — P37
Short interest change +13.5% — P71
Worst FTD 0.01% of shares — P46
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 27,780,646 | 24,478,152 | +3,302,494 | 2.20 |
| 2026-06-15 | 24,478,152 | 22,683,612 | +1,794,540 | 1.70 |
| 2026-05-29 | 22,683,612 | 21,723,616 | +959,996 | 1.95 |
| 2026-05-15 | 21,723,616 | 13,996,269 | +7,727,347 | 1.21 |
| 2026-04-30 | 13,996,269 | 17,019,927 | -3,023,658 | 1.00 |
| 2026-04-15 | 17,019,927 | 19,927,815 | -2,907,888 | 1.11 |
| 2026-03-31 | 19,927,815 | 24,696,357 | -4,768,542 | 1.10 |
| 2026-03-13 | 24,696,357 | 28,261,287 | -3,564,930 | 1.19 |
| 2026-02-27 | 28,261,287 | 26,973,270 | +1,288,017 | 1.00 |
| 2026-02-13 | 26,973,270 | 31,693,294 | -4,720,024 | 1.00 |
| 2026-01-30 | 31,693,294 | 28,156,368 | +3,536,926 | 1.38 |
| 2026-01-15 | 28,156,368 | 32,384,787 | -4,228,419 | 1.29 |
| 2025-12-31 | 32,384,787 | 28,487,274 | +3,897,513 | 1.79 |
| 2025-12-15 | 28,487,274 | 29,593,438 | -1,106,164 | 2.09 |
| 2025-11-28 | 29,593,438 | 27,691,852 | +1,901,586 | 1.22 |
| 2025-11-14 | 27,691,852 | 28,242,397 | -550,545 | 1.16 |
| 2025-10-31 | 28,242,397 | 26,671,758 | +1,570,639 | 2.35 |
| 2025-10-15 | 26,671,758 | 31,458,880 | -4,787,122 | 2.18 |
| 2025-09-30 | 31,458,880 | 28,735,135 | +2,723,745 | 1.93 |
| 2025-09-15 | 28,735,135 | 25,777,443 | +2,957,692 | 2.19 |
| 2025-08-29 | 25,777,443 | 21,020,029 | +4,757,414 | 1.58 |
| 2025-08-15 | 21,020,029 | 20,756,474 | +263,555 | 1.00 |
| 2025-07-31 | 20,756,474 | 23,584,063 | -2,827,589 | 1.00 |
| 2025-07-15 | 23,584,063 | 25,701,254 | -2,117,191 | 3.49 |
Showing 1–24 of 24 settlements
Key facts
CIK
353278
CUSIP
670100205
13F (30d)
115 filings
114 filers
Visit website
Investor relations